Find Academic Supervisors

• Genome Regulation
• Epigenomics
• Chromatin Architecture
• +5 more

Suhn K. Rhie, PhD, is an Assistant Professor in the Department of Biochemistry and Molecular Medicine at the Keck School of Medicine of the University of Southern California, where she leads the Rhie Lab within the Norris Comprehensive Cancer Center. Her research program centers on understanding gene regulation in normal and diseased cells through integrative genomic approaches, with a focus on epigenetic mechanisms in cancer biology. Dr. Rhie's work spans four interconnected research pillars: Genome Wide Association Studies (GWAS), Regulatory Elements, Chromatin Interactions, and Transcription Factors. She investigates epigenomic dysregulation in prostate and bladder cancers, with dedicated emphasis on health disparities affecting African American populations. Her lab develops computational tools like TENET for regulatory network tracing and Methyl-Micro-C for multi-omic chromatin profiling, bridging wet-lab experimentation with advanced bioinformatics. Analysis of her 2023-2025 publications reveals consistent innovation in epigenomic technologies, particularly in characterizing DNA methylation signatures across racial groups in prostate cancer, dissecting 3D chromatin architecture in tumorigenesis, and developing methods for simultaneous assessment of multiple epigenetic layers. Her work frequently addresses therapy resistance mechanisms and racial disparities through multi-ethnic genomic studies. Dr. Rhie mentors trainees in her laboratory and secures competitive research funding to advance her agenda on cancer epigenetics and health equity, with publications demonstrating sustained productivity in high-impact venues despite the absence of explicitly listed grants in available materials. The Rhie Lab operates at the intersection of computational biology and experimental cancer research within USC's Norris Comprehensive Cancer Center. Her team leverages cutting-edge genomic technologies to map regulatory landscapes in cancer, with particular focus on translating epigenetic discoveries into clinical applications for personalized cancer care and addressing systemic disparities in cancer outcomes through rigorous molecular analysis.

Susanne GerberView profile

Professor

• Bioinformatics
• Computational Genomics
• Systems Biology
• +2 more

Susanne Gerber is a Professor at iDNA and Adjunct Director at the Institute of Molecular Biology (IMB), Johannes Gutenberg University Mainz (JGU), affiliated with the Faculty of Biology's Bioinformatics department. Her academic journey includes an Assistant Professorship in Bioinformatics at JGU (2015-2020) and postdoctoral research at Università della Svizzera italiana. Her educational background comprises a PhD in Biophysics from Humboldt University of Berlin (2011), an M.Sc. in Bioinformatics from Free University of Berlin and Konrad Zuse Institute (2007), and a B.Sc. in Bioinformatics from Free University of Berlin and Max Planck Institute (2004). Dr. Gerber's research spans Bioinformatics, Computational Genomics, Systems Biology, Molecular Evolution, and Neuroinformatics , focusing on developing computational frameworks for genomic analysis, neurodegenerative disease modeling, and microbiome interactions. Her work integrates machine learning with multi-omics data to address complex biological questions in molecular evolution and neural systems. Analysis of her 15 most recent publications (2024-2025) reveals a strong emphasis on nanopore sequencing applications for RNA modification detection, deep learning frameworks for genomic data enhancement, and neurobehavioral modeling using AI-driven approaches. Key thematic clusters include epitranscriptomics, chromatin dynamics, and computational psychiatry with ethical AI considerations. Her methodological innovations include tools like COMET for network analysis, CCUT for chromatin data enhancement, and ModiDeC for RNA modification classification, demonstrating translational impact across genomics and neuroscience. Dr. Gerber leads research groups at IMB and iDNA focusing on computational genomics, advising students in bioinformatics and securing grants for AI-driven genomic analysis. Her labs develop open-source tools for nanopore data processing and neuroimaging analysis, fostering collaboration between computational and experimental biologists.

• RNA Biology
• Cancer Biology
• Translational Regulation
• +3 more

Stephan Vagner serves as Director of Research Unit Genome Integrity, RNA and Cancer (UMR3348) and Team Leader of RNA Biology, Signalling and Cancer (U1278) at Institut Curie in Orsay, while holding a professorship at Ecole Polytechnique since 2018. His leadership roles include Site Coordinator of the Research Center and Director of CNRS UMR3348/INSERM U1278 since 2020. Dr. Vagner's research focuses on RNA regulations and RNA-binding proteins in cancer biology, with three primary axes: (1) DNA damage response mechanisms including intronic polyadenylation, (2) Tumor-intrinsic resistance to targeted therapies through mRNA translation reprogramming, and (3) Tumor cell-environment crosstalk in melanoma and leukemia. His work employs biochemical analyses, genome-wide RNA studies, and in vivo tumor models across cutaneous melanoma, breast cancer, and acute T lymphoblastic leukemia. Analysis of his publication history reveals sustained expertise in translational regulation during therapy resistance, with recent emphasis on unconventional RNA-binding activities of metabolic enzymes and genotoxic stress responses. His collaborative network spans Institut Curie, CNRS, Inserm, and Ecole Polytechnique. As Team Leader, he mentors researchers across multiple projects investigating RNA-protein interactions in cancer progression. His laboratory utilizes advanced techniques including RNA-seq, 3'seq, polysome profiling, and iCLIP for RNA-protein interaction studies. The RNA Biology, Signalling and Cancer team operates within the Genome Integrity, RNA and Cancer unit, focusing on co-/post-transcriptional gene regulation in therapeutic contexts through biochemical, genomic, and phenotypic analyses.

Michiel VermeulenView profile

Professor

• Systems Biology
• Proteomics
• Cellular Differentiation
• +8 more

Michiel Vermeulen is a Full Professor in Proteomics and Chromatin Biology at the Department of Molecular Biology, Radboud University Nijmegen, Netherlands. He previously held positions as Associate and Assistant Professor at University Medical Center Utrecht (2009-2014) and completed postdoctoral work at Max Planck Institute for Biochemistry (2005-2009) and a PhD at Radboud University (2000-2005). His research focuses on integrative omics approaches to study gene expression regulation in development and disease, particularly through chromatin interactions and post-translational modifications. Education: PhD in Molecular Biology, Radboud University Nijmegen (2000-2005) Postdoc in Proteomics & Signal Transduction, Max Planck Institute Munich (2005-2009) His work pioneers quantitative mass spectrometry technologies to analyze chromatin-associated proteins, including m6A RNA modifications and ubiquitin signaling. He has published 97 papers and received multiple accolades, including ERC Starting and Consolidator Grants, a VIDI award, and membership in the Oncode Institute. His lab leads collaborative studies on chromatin readers, DNA damage response, and transcriptional regulation. Scientific Awards: ERC Consolidator Grant (2017) ERC Starting Grant (2012) Vernieuwingsimpuls VIDI award (2009) Max Planck Institute Junior Research Award (2008) Van Nieuwenhoven Award for Best Master Student (2000) Oncode Institute Founding Member (2017) Vermeulen's lab collaborates internationally and mentors 6 PhD students, 6 postdocs, and technicians, emphasizing high-impact interdisciplinary research in chromatin biology and systems-level gene regulation.

Ade WhitehouseView profile

Professor

• Molecular Virology
• RNA Biology
• Epitranscriptomics
• +10 more

Professor Ade Whitehouse is a leading researcher in molecular virology at the University of Leeds, Faculty of Biological Sciences, within the School of Molecular and Cellular Biology. His research focuses on understanding how oncogenic viruses such as Kaposi's sarcoma-associated herpesvirus (KSHV) and Merkel cell polyomavirus (MCPyV) hijack host cell machinery to replicate and drive carcinogenesis. His research interests include: Role of RNA modifications (especially m6A methylation) in viral infection Virus-induced specialized ribosomes and translational control Manipulation of non-coding RNA (ncRNA) regulatory networks by viruses Development of novel antiviral strategies through structural-based rational drug design His lab employs cutting-edge transcriptomic and quantitative proteomic approaches to identify critical virus-host interactions as targets for therapeutic intervention. Although vaccines for some oncogenic viruses exist, none are available for KSHV and MCPyV, making his work on novel antiviral compounds particularly significant. The trends in his research—spanning RNA biology, epitranscriptomics, and translational regulation—reflect a strong interdisciplinary focus on molecular mechanisms of viral pathogenesis and innovative therapeutic development. He has not listed any scientific awards in the provided text. Professor Whitehouse advises research students and leads a dynamic research group, though specific names of students are not mentioned. His team utilizes virtual high-throughput screening and molecular modeling to design small-molecule inhibitors targeting essential virus-host interactions. Grants or funding sources are not specified, but the scope of his research implies substantial external support. The Whitehouse laboratory is actively involved in elucidating complex regulatory networks involving RNA modifications and ribosome specialization during viral infection, positioning it at the forefront of molecular virology and RNA-based disease mechanisms.

Tameka BaileyView profile

Assistant Professor

• Breast cancer brain metastasis
• Vascular dysfunction
• Signal Transduction
• +3 more

Dr. Tameka Bailey is an Assistant Professor in the Department of Biological Sciences at Arkansas State University , affiliated with the Beck College of Sciences & Mathematics . Her research focuses on molecular mechanisms in vascular biology and cancer metastasis. Education: BS (2002) from University of Arkansas at Pine Bluff; Ph.D. (2007) from University of Arkansas at Fayetteville Her research interests include breast cancer brain metastasis, vascular dysfunction, signal transduction, cell-to-cell communication, protein-to-protein interactions, and epitranscriptomics. She investigates angiopoietin-like proteins in vascular permeability and vasodilation in health and disease. Contact: Office in Lab Sciences East Room 314, phone 870-972-8175 , email tambailey@AState.edu . A native of Gould and Dumas, Arkansas, her work bridges cellular biology with vascular pathologies.

• Functional genomics
• tRNA biology
• Microbiome
• +4 more

Professor Tao Pan is a leading researcher in RNA biology at the University of Chicago's Department of Biochemistry and Molecular Biology. His laboratory pioneers methodologies for studying tRNA dynamics, epitranscriptomics, and microbiome-host interactions through innovative sequencing technologies. His research spans three interconnected domains: tRNA biology : Developing high-throughput sequencing to measure tRNA abundance, charging, and modifications, revealing roles in translational control and extratranslational functions Microbiome characterization : Creating tRNA-seq as an RNA-based alternative to 16S/shotgun metagenomics to capture dynamic microbiome activity Epitranscriptomics : Investigating mRNA modifications like m6A in gene regulation, discovering the 'm6A switch' mechanism affecting RNA structure and protein binding His publication trends demonstrate consistent innovation in RNA modification mapping techniques, with recent work focusing on nanopore sequencing applications, microbiome-induced epitranscriptomic reprogramming, and therapeutic mRNA engineering. Key recurring themes include tRNA modification dynamics, host-microbiome crosstalk, and RNA modification detection methodologies. Scientific recognition includes: NIH Director's Pioneer Award (2011-2016) NIH EUREKA Award (2009-2013) AAAS Fellow (2015) Multiple early-career cancer research awards His laboratory maintains substantial NIH funding through multiple R01 grants (current awards totaling >$5M annually), focusing on tRNA sequencing applications in cancer (R33CA272357), microbiome-host interactions (R21AI169280), and snoRNA functions (R01HG012780). The Pan Lab has established tRNA-seq as a novel microbiome characterization platform and pioneered discoveries in m6A-mediated RNA structural switching. Research infrastructure includes development of specialized sequencing technologies for simultaneous tRNA modification and fragmentation analysis, with recent expansion into nanopore-based direct RNA modification detection. Current work explores therapeutic applications of tRNA modification knowledge in cancer and infectious disease contexts.

• Genomics
• Epigenetics
• Systems Biology
• +7 more

Gary Hon is an Assistant Professor at the University of Texas Southwestern Medical Center (UTSW), jointly affiliated with the Cecil H. and Ida Green Center for Reproductive Biology Sciences and the Lyda Hill Department of Bioinformatics. His research lies at the intersection of genomics, epigenetics, and systems biology, with a focus on decoding the regulatory complexity of the human genome. His research interests include: Understanding the molecular basis of cell state for applications in regenerative medicine Elucidating how non-coding genetic variants contribute to development and disease Developing integrative techniques combining gene regulation, epigenetics, genome engineering, and single-cell genomics Advancing bioinformatics tools for analyzing chromatin and transcriptional regulation The trends across his recent publications reveal a strong emphasis on enhancer biology, epigenetic modifications (especially 5mC and 5hmC), single-cell functional genomics, and the development of novel molecular tools such as in situ chromatin capture and combinatorial perturbation assays. His work frequently leverages CRISPR-based technologies and high-throughput sequencing to dissect gene regulatory networks. Dr. Hon has received significant recognition for his innovative research, including: CPRIT Scholar NIH Director’s New Innovator Award Dr. Hon leads the Hon Lab, which actively develops and applies systems-level approaches to study genome regulation. His collaborative research involves advising graduate students and postdoctoral fellows, many of whom appear as co-authors on his publications. While specific grant details are not listed, his prestigious awards suggest substantial federal and state funding support for his high-impact, interdisciplinary research program.

Alfredo CastelloView profile

Professor

• RNA-binding proteins
• Virology
• Systems virology
• +5 more

Professor Alfredo Castello is a Professor in Systems Virology at the MRC-University of Glasgow Centre for Virus Research within the Institute of Infection, Immunity and Inflammation at the University of Glasgow's College of Medical, Veterinary and Life Sciences. With an active research program and numerous recent publications, he leads the Castello Lab which focuses on understanding RNA-binding proteins in virus infection. Castello's research interests center around the critical role of cellular RNA-binding proteins (RBPs) in viral infections. His work reveals how viruses exploit host RBPs for replication while cells utilize RBPs as part of their antiviral defense. His lab employs innovative approaches to discover cellular proteins that interact with viral RNA during infection, combining cell and molecular biology, RNA biology, virology, and 'omic' technologies to understand host-virus interactions at a systems level. Analysis of Castello's recent publications shows a strong focus on RNA-protein interactions in viral infections across multiple viral systems including alphaviruses, HIV-1, SARS-CoV-2, and other RNA viruses. His work spans from fundamental RNA biology to translational applications, with particular emphasis on identifying host factors that could serve as targets for broad-spectrum antivirals. ERC consolidator Grant: Towards the discovery of cellular RNA-binding proteins with master regulatory roles in virus infection (2021-2026) MRC Career Development Award: Proteome-Wide Identification of RNA-Binding Proteins Playing Critical Roles in Virus Infection (2021-2022) Marie Curie postdoctoral fellowship: Structural basis of TRIM25 and RIPLET mediated antiviral response (2023) Castello actively supervises multiple PhD students and postdoctoral researchers in the Castello Lab, including Rozeena Arif, Namah Raut, Innes Jarmson, and others. His research group receives substantial funding through multiple grants including RBP-ReguNet (2023-2027) and Understanding the Roles of Cellular RNA-Binding Proteins in HIV-1 Infection (2023). The lab maintains active collaborations both within the University of Glasgow and with external institutions worldwide. The Castello Lab operates as a multidisciplinary research unit combining expertise in molecular virology, cellular biology, RNA biology, and computational approaches. The group has developed innovative methods for identifying RNA-binding proteins in cells, representing significant breakthroughs in understanding protein-RNA interactions during viral infection.

Rajesh RaoView profile

Associate Professor

• Ophthalmology
• Oncology
• Stem Cell Research
• +4 more

Rajesh Rao is an Associate Professor in the Department of Ophthalmology and Visual Sciences at the University of Michigan. His work spans ocular oncology, retinal diseases, and stem cell biology, with a focus on translational applications. Key Research Areas: Vitreoretinal lymphoma diagnostics using liquid biopsy Stem cell therapies for age-related macular degeneration (AMD) Role of MYD88 L265P mutation in ocular CLL diagnosis Quiescence mechanisms in embryonic stem cells Collaborations: Work with Qiang Li, Hakan Demirci, Noah Brown, Bryan Betz, and others Multidisciplinary teams in ophthalmology, oncology, and stem cell research Recent publications in Nature Communications , Ophthalmology Retina , and Stem Cell Reports highlight his contributions to ocular lymphoma detection and stem cell fate regulation. No scientific awards or student advisement details were explicitly mentioned in available data.

Jeremy BirdView profile

Assistant Professor

• Gene Expression Regulation
• Transcription Mechanisms
• RNA Polymerase Function
• +3 more

Jeremy Bird is an Assistant Professor in the Department of Biological Sciences at the University of Delaware’s College of Arts & Sciences. His research focuses on the interplay between cellular metabolism and transcriptional regulation, particularly the role of non-canonical initiating nucleotides (NCINs) in RNA capping. He holds a BS from Loyola University in Maryland, a PhD from Cornell University, and completed post-doctoral research at Rutgers University’s Waksman Institute of Microbiology. Dr. Bird’s work investigates how metabolic states influence transcription by RNA polymerases, with emphasis on mitochondrial RNAPs and their use of NAD(H) and dpCoA as capping metabolites. His lab employs genetic, biochemical, and next-generation sequencing approaches to study transcription initiation, elongation, and termination dynamics. Key discoveries include NAD-cap-dependent regulation of RNA stability and its redox-state sensitivity, suggesting a novel epitranscriptomic regulatory layer. Recent projects explore functional implications of metabolite caps, metabolic/transcriptional crosstalk, and applications to mitochondrial dysfunction in diseases. His research has been published in high-impact journals, with a focus on mechanistic studies of transcriptional regulation across prokaryotes and eukaryotes.

Alexandra LusserView profile

Professor

• Chromatin remodeling
• Chromatin assembly
• Epigenetics
• +5 more

Professor Alexandra Lusser serves as Professor and Deputy Head in the Department of Molecular Biology at Innsbruck Medical University, where she leads the Chromatin and Epigenetics Laboratory. Her research focuses on understanding the molecular mechanisms of chromatin assembly, remodeling, and epigenetic regulation at both DNA and RNA levels. Professor Lusser completed her PhD at the University of Innsbruck in 1998, followed by postdoctoral training at the University of California, San Diego (2001-2004) in the laboratory of Professor JT Kadonaga. She joined Innsbruck Medical University as Assistant Professor in 2004, achieved her Habilitation for Molecular Biology in 2008, was promoted to Associate Professor, and became a full Professor in 2019. Her research program investigates how eukaryotic DNA is organized in chromatin and how this organization affects DNA metabolism processes including transcription, replication, repair, and recombination. A significant portion of her work examines ATP-dependent chromatin assembly and remodeling mechanisms, variant histone assembly, and epigenetic mechanisms at the mRNA level, particularly mRNA base modifications such as 5-methylcytosine and their roles in mRNA metabolism and translation. Her publications reveal a strong focus on developing and applying innovative biochemical and genomic techniques to study RNA modifications and chromatin dynamics. Professor Lusser's extensive publication record spanning from 1996 to the present demonstrates consistent contributions to the fields of chromatin biology and RNA epigenetics. Her recent work shows particular emphasis on developing novel sequencing methods for RNA modification analysis, exploring the functional consequences of RNA modifications, and investigating the relationship between chromatin remodeling factors and neurological functions. HOECHST Award (1998) APART 3-year postdoctoral fellowship from the Austrian Academy of Sciences (2001) START Prize from the Ministry of Science and Research (2005) Member of the Young Curia of the Austrian Academy of Sciences (2008-2016) Research Award from the State Capital Innsbruck (2009) As Deputy Head of the Department of Molecular Biology, Professor Lusser contributes to departmental leadership while maintaining an active research program. Her laboratory has developed several important methodologies including TUC-Seq for measuring mRNA transcription and degradation rates, bisulfite sequencing for detecting 5-methylcytosine in RNA, and other innovative approaches for studying RNA modifications. Her work bridges molecular biology, biochemistry, and genomics, with implications for understanding fundamental biological processes and potential applications in disease research.

Jenny PerssonView profile

Professor

• Cancer Metastasis
• Molecular Oncology
• Targeted Cancer Therapy
• +5 more

Professor Jenny Persson leads cutting-edge cancer metastasis research at Umeå University's Department of Molecular Biology within the Faculty of Medicine. Her work focuses on deciphering molecular mechanisms driving cancer spread and developing targeted therapies, particularly for prostate and breast cancers. She maintains active laboratory facilities at the Hospital Area (Plats 6K and 6L) in Umeå and serves on the Faculty of Medicine Council for AI and Autonomous Systems. Her research centers on lipid kinase pathways (PIP5K1α/PI3K/AKT), androgen receptor signaling, and tumor microenvironment interactions. Key interests include: Mechanisms of bone metastasis in prostate/breast cancers Development of PIP5K1α inhibitors (e.g., ISA-2011B) Nanoparticle-based cancer detection systems Integration of AI for diagnostic algorithms and treatment prediction Recent publications demonstrate a strong shift toward AI-enhanced diagnostics, liquid biopsies, and nanoparticle therapeutics. Persson directs significant research funding including EU framework projects (GlycoImaging 721297, REVERT 848098-H2020-SC1-2) and grants from the Swedish Cancer Foundation, Swedish Research Council, and Swedish Children Cancer Foundation. She serves on the Research Grant Review Committee of the Swedish Cancer Foundation and previously held positions as Professor and Head of Experimental Cancer Research at Lund University and Honorary Professor at the University of Nottingham. Her laboratory maintains extensive national and international collaborations with clinical and preclinical researchers, focusing on translating molecular discoveries into clinical applications for metastatic cancers.

Patrick PaddisonView profile

Professor

• Cancer Stem Cells
• Functional Genomics
• Genome Editing
• +5 more

Patrick Paddison is a Professor in the Human Biology Division at Fred Hutchinson Cancer Center, where he leads the Paddison Lab. His research employs cutting-edge genetic techniques, including CRISPR-Cas9 and RNAi, to investigate stem cell biology and cancer, with a particular focus on cancer stem cells in glioblastoma and the role of epigenetics and epitranscriptomics in development and disease. His educational background includes a PhD in Biological Sciences from Cold Spring Harbor Laboratory (2004) and dual bachelor's degrees in Psychology and Molecular Biology and Genetics from The Evergreen State College (1996). Dr. Paddison's research centers on functional genomics to dissect gene networks in stem and progenitor cells. His lab uses genome-wide screening to identify genes critical for stem cell self-renewal, differentiation, and survival, with applications in cancer therapy. Key areas include: Cancer stem cell biology, particularly quiescent states in glioblastoma Epigenetic and epitranscriptomic regulation (e.g., N6-adenosine methylation in erythropoiesis) Protein domain annotation via CRISPR tiling mutagenesis Developmental transitions in embryonic and somatic stem cells Analysis of his recent publications reveals a shift from RNAi-based methods to CRISPR-Cas9, with a sustained focus on cancer stem cells and the molecular mechanisms underlying developmental processes. His work increasingly integrates single-cell technologies and patient-derived models to address therapeutic resistance. Dr. Paddison mentors graduate students and postdoctoral fellows in his lab, fostering expertise in functional genomics and genome editing. While specific grant details are not provided, his extensive publication record indicates sustained funding for innovative research in cancer biology and stem cell science. The Paddison Lab is a dynamic research environment that combines high-throughput screening, molecular biology, and computational analysis to uncover fundamental biological mechanisms with translational potential in oncology.

• Transposable Elements
• Genome Plasticity
• Epigenetics
• +3 more

Dr. Jungnam Cho is an Associate Professor in the Department of Biosciences at Durham University. Previously, he served as a group leader at the CAS-JIC Centre of Excellence for Plant and Microbial Sciences (2018–2023) after completing postdoctoral research at the University of Cambridge (2013–2018). He holds a BSc (2007) and PhD (2013) from Seoul National University. His research focuses on transposable elements ("jumping genes") in plants, exploring their roles in genome evolution, epigenetic regulation, and crop improvement. Using Arabidopsis and rice as models, his lab combines molecular biology, biochemistry, and computational tools to dissect transposon mobilization mechanisms. Key areas include RNA methylation, genome plasticity, and epitranscriptomics. Recent grants include a BBSRC standard research grant (2025) and funding from the Great Britain Sasakawa Foundation (2024). He supervises PhD students Ben Shone and Seunghui Mun, with additional training roles for interns and undergraduates. Collaborations extend to institutions like Zhejiang University and Fudan University. Lab activities emphasize translational applications, such as enhancing crop genetic diversity and addressing global food security through epigenetic insights. Current projects include studies on bamboo epigenetic reprogramming and heat-activated retrotransposons in Arabidopsis.